Gleason Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8K | Hold |
6,670
| – | – | ﹤0.01% | 162 |
|
|
2025
Q1 | $14.7K | Hold |
6,670
| – | – | ﹤0.01% | 154 |
|
|
2024
Q4 | $10.2K | Hold |
6,670
| – | – | ﹤0.01% | 166 |
|
|
2024
Q3 | $13.3K | Hold |
6,670
| – | – | ﹤0.01% | 157 |
|
|
2024
Q2 | $23.3K | Hold |
6,670
| – | – | ﹤0.01% | 154 |
|
|
2024
Q1 | $18.5K | Hold |
6,670
| – | – | ﹤0.01% | 149 |
|
|
2023
Q4 | $11.3K | Buy |
+6,670
| New | +$11.3K | ﹤0.01% | 175 |
|